- Home
- CRMD vs AMC Comparison
CRMD vs AMC Comparison
Compare CRMD & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRMD | AMC |
|---|---|---|
| Founded | 2006 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 509.9M | 577.2M |
| IPO Year | 2009 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CRMD | AMC |
|---|---|---|
| Price | $7.22 | $1.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $15.20 | $2.03 |
| AVG Volume (30 Days) | 1.2M | ★ 25.6M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 2.04 | N/A |
| Revenue | $311,709,000.00 | ★ $4,848,900,000.00 |
| Revenue This Year | $0.30 | $10.60 |
| Revenue Next Year | N/A | $4.72 |
| P/E Ratio | $3.51 | ★ N/A |
| Revenue Growth | ★ 617.03 | 4.57 |
| 52 Week Low | $6.13 | $0.93 |
| 52 Week High | $17.43 | $4.08 |
Technical Indicators
Market Signals| Indicator | CRMD | AMC |
|---|---|---|
| Relative Strength Index (RSI) | 59.78 | 69.53 |
| Support Level | $6.14 | $0.93 |
| Resistance Level | $7.44 | $1.54 |
| Average True Range (ATR) | 0.24 | 0.08 |
| MACD | 0.12 | 0.05 |
| Stochastic Oscillator | 82.89 | 86.43 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.